Use of the Michigan Neuropathy Screening Instrument as a measure of distal
symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes
Control and Complications Trial/Epidemiology of Diabetes Interventions and
Complications.
Authors Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, Feldman EL
Submitted By Eva Feldman on 1/30/2013
Status Published
Journal Diabetic medicine : a journal of the British Diabetic Association
Year 2012
Date Published 7/1/2012
Volume : Pages 29 : 937 - 944
PubMed Reference 22417277
Abstract The Michigan Neuropathy Screening Instrument (MNSI) is used to assess distal
symmetrical peripheral neuropathy in diabetes. It includes two separate
assessments: a 15-item self-administered questionnaire and a lower extremity
examination that includes inspection and assessment of vibratory sensation and
ankle reflexes. The purpose of this study was to evaluate the performance of the
MNSI in detecting distal symmetrical peripheral neuropathy in patients with Type
1 diabetes and to develop new scoring algorithms.


Investigators with authorship
NameInstitution
Eva FeldmanUniversity of Michigan

Complications